Journal of Neoplasms

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Neoplasms -melanoma-Rob	van den Brom


University Medical Center Groningen

Send an Email

Rob van den Brom


Hanzeplein 1
9700 RB  Groningen
the Netherlands

Research Interests:

  • melanoma
  • renal cell carcinoma
  • GIST
  • immune checkpoint inhibitors



  1. Systemic vasculitis developed after immune checkpoint inhibition.
  2. Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition.
  3. Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.
  4. Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma.
  5. Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).
  6. Effect of vemurafenib on a V600R melanoma brain metastasis.
  7. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
  8. Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer.